Following traumatic injury, the formation of a glial scar and deposition of
extracellular matrix (ECM) contributes to the regeneration failure in the
adult mammalian central nervous system (CNS). Using a postcommissural forni
x transection as a brain lesion model in rat, we have previously shown that
the collagenous basement membrane (BM) at the lesion site is a major imped
iment for axon regeneration. Deposition of BM in this lesion model can be d
elayed by administration of the iron chelator 2,2'-bipyridine (BPY), an inh
ibitor of prolyl 4-hydroxylase (PH), a key enzyme of collagen biosynthesis.
To examine whether this potential therapeutic approach is transferable to
other CNS regions, we have chosen the mechanically lesioned rat spinal cord
to investigate the effects of BPY administration on BM formation. Due to t
he close proximity of the lesion zone to meningeal fibroblasts, a cell-type
secreting large amounts of collagen IV, BM deposition was much more extens
ive in the spinal cord than in the brain lesion. Neither immediate injectio
ns nor continuous application of BPY resulted in a detectable reduction of
BM formation in the spinal cord. Only a combination of anti-scarring treatm
ents including (i) injection of the more potent PH inhibitor [2,2'-bipyridi
ne]-5,5'-dicarboxylic acid (BPY-DCA), (ii) selective inhibition of fibrobla
st proliferation and ECM production by S-Br-cAMP, and (iii) continuous appl
ication of BPY-DCA, reduced the lesion-induced BM significantly. The presen
t results clearly demonstrate, that the exclusive application of BPY accord
ing to a protocol designed for treatment of brain lesions is not sufficient
to reduce BM formation in the lesioned adult rat spinal cord. (C) 2001 Els
evier Science B.V. All rights reserved.